Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Adial Pharmaceuticals Analyst Ratings
Adial Pharmaceuticals Initiated With a Buy at Rodman & Renshaw
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating
Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)
Brookline Capital Reiterates Buy on Adial Pharmaceuticals, Maintains $6 Price Target
ADial Pharmaceuticals Cut to Hold From Buy by Maxim Group
Adial Pharmaceuticals Analyst Ratings
Maxim Group Adjusts Adial Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating
Brookline Capital Markets Keeps Their Buy Rating on Adial Pharmaceuticals (ADIL)
Adial Pharmaceuticals (ADIL) Receives a Buy from Maxim Group
Unlock the Full List